Načítá se...

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is the most common benign tumor in males. Androgen/androgen receptor (AR) signaling plays a key role in the development of BPH; its alterations cause an imbalance between prostate cell growth and apoptosis. Furthermore, chronic inflammation and oxidative stress, wh...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Antioxidants (Basel)
Hlavní autoři:	D’Amico, Ramona, Genovese, Tiziana, Cordaro, Marika, Siracusa, Rosalba, Gugliandolo, Enrico, Peritore, Alessio Filippo, Interdonato, Livia, Crupi, Rosalia, Cuzzocrea, Salvatore, Di Paola, Rosanna, Fusco, Roberta, Impellizzeri, Daniela
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI 2021
Témata:	Article
On-line přístup:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8300753/ https://ncbi.nlm.nih.gov/pubmed/34202665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10071014
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo otaguje tento záznam!

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia

Podobné jednotky